Search

Author/Creator Bories, Jean‐Christophe

1. CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment. Issue 3 (21st June 2022)

Authors:
Abecassis, Audrey; Roders, Nathalie; Fayon, Maxime; Choisy, Caroline; Nelson, Elisabeth; Harel, Stephanie; Royer, Bruno; Villesuzanne, Camille; Talbot, Alexis; Garrick, David; Goodhardt, Michele; Fermand, Jean‐Paul; Burbridge, Mike; Arnulf, Bertrand; Bories, Jean‐Christophe
Journal:
EJHaem
Issue:
Volume 3:Issue 3(2022)
Page Start:
970
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The Sec61 translocon is a therapeutic vulnerability in multiple myeloma. Issue 3 (11th January 2022)

Authors:
Domenger, Antoine; Choisy, Caroline; Baron, Ludivine; Mayau, Véronique; Perthame, Emeline; Deriano, Ludovic; Arnulf, Bertrand; Bories, Jean‐Christophe; Dadaglio, Gilles; Demangel, Caroline
Journal:
EMBO molecular medicine
Issue:
Volume 14:Issue 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search